Q3 2024 Holdings
Filed 2024-11-14 | 66 holdings | $888.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $105.9M | 1,450,000 | 11.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $88.1M | 530,000 | 9.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $46.1M | 550,000 | 5.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $39.6M | 750,000 | 4.5% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $35.0M | 1,050,000 | 3.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $33.8M | 160,000 | 3.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $27.0M | 300,000 | 3.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.8M | 290,000 | 3.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $26.6M | 275,000 | 3.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $23.0M | 200,000 | 2.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $23.0M | 275,000 | 2.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $22.7M | 200,000 | 2.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $22.1M | 500,000 | 2.5% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $18.6M | 120,000 | 2.1% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $16.5M | 400,000 | 1.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $15.9M | 350,000 | 1.8% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $15.8M | 250,000 | 1.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $15.3M | 300,000 | 1.7% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $13.4M | 1,275,000 | 1.5% |
| Edgewise Therapeutics Inc(EWTX)Call | COM | 28036F105 | $13.3M | 500,000 | 1.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $12.3M | 375,000 | 1.4% |
| Cooper COS Inc(COO) | COM | 216648501 | $12.1M | 110,000 | 1.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.6M | 200,000 | 1.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $11.1M | 220,000 | 1.2% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $10.2M | 300,000 | 1.1% |
| Fresenius Medical Care AG(FMS) | SPONSORED ADR | 358029106 | $9.6M | 450,000 | 1.1% |
| Bruker Corp(BRKR) | COM | 116794108 | $9.3M | 135,000 | 1.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $9.1M | 175,000 | 1.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $8.9M | 10,000 | 1.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.0M | 120,000 | 0.9% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $8.0M | 400,000 | 0.9% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $7.5M | 1,800,000 | 0.8% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $7.4M | 30,000 | 0.8% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $7.3M | 500,000 | 0.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $7.0M | 150,000 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.9M | 25,000 | 0.8% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $6.8M | 800,000 | 0.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.6M | 350,000 | 0.7% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $6.4M | 150,000 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $5.9M | 50,000 | 0.7% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $5.7M | 125,000 | 0.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.7M | 250,000 | 0.6% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $5.7M | 200,000 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $5.4M | 80,000 | 0.6% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $4.7M | 20,000 | 0.5% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $4.6M | 2,375,000 | 0.5% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $4.5M | 100,000 | 0.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.5M | 200,000 | 0.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.3M | 356,000 | 0.5% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $4.1M | 1,000,000 | 0.5% |